Dogwood Therapeutics: SEC filing sets up resale of 4,098,360 common shares
Dogwood Therapeutics has filed with the SEC to register up to 4,098,360 common shares for resale, according to an SEC filing dated October 30, 2026.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
According to an SEC filing published on October 30, 2026, Dogwood Therapeutics Inc has submitted paperwork to the regulator covering the possible sale of up to 4,098,360 of its common shares.
The document indicates that these shares could be sold by existing holders in the open market once the registration takes effect.
why it matters
Registering shares for resale makes additional stock available to sell. That can increase the supply of the shares and affect how the price moves, so investors often look at who holds them.
tags
instruments
sources
- Dogwood Therapeutics - Files For Resale Of Up To 4,098,360 Common Shares — SEC Filing, 30 October 2026 at 21:23 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗